Literature DB >> 16235032

Influence of electromagnetic interference on implanted cardiac arrhythmia devices in and around a magnetically levitated linear motor car.

Motoyuki Fukuta1, Noboru Mizutani, Katsuhisa Waseda.   

Abstract

This study was designed to determine the susceptibility of implanted cardiac arrhythmia devices to electromagnetic interference in and around a magnetically levitated linear motor car [High-Speed Surface Transport (HSST)]. During the study, cardiac devices were connected to a phantom model that had similar characteristics to the human body. Three pacemakers from three manufacturers and one implantable cardioverter-defibrillator (ICD) were evaluated in and around the magnetically levitated vehicle. The system is based on a normal conductive system levitated by the attractive force of magnets and propelled by a linear induction motor without wheels. The magnetic field strength at 40 cm from the vehicle in the nonlevitating state was 0.12 mT and that during levitation was 0.20 mT. The magnetic and electric field strengths on a seat close to the variable voltage/variable frequency inverter while the vehicle was moving and at rest were 0.13 mT, 2.95 V/m and 0.04 mT, 0.36 V/m, respectively. Data recorded on a seat close to the reactor while the vehicle was moving and at rest were 0.09 mT, 2.45 V/m and 0.05 mT, 1.46 V/m, respectively. Measured magnetic and electric field strengths both inside and outside the linear motor car were too low to result in device inactivation. No sensing, pacing, or arrhythmic interactions were noted with any pacemaker or ICD programmed in either bipolar and unipolar configurations. In conclusion, our data suggest that a permanent programming change or a device failure is unlikely to occur and that the linear motor car system is probably safe for patients with one of the four implanted cardiac arrhythmia devices used in this study under the conditions tested.

Entities:  

Mesh:

Year:  2005        PMID: 16235032     DOI: 10.1007/s10047-005-0305-0

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  7 in total

Review 1.  Interference in implanted cardiac devices, Part I.

Authors:  Sergio L Pinski; Richard G Trohman
Journal:  Pacing Clin Electrophysiol       Date:  2002-09       Impact factor: 1.976

Review 2.  Interference in implanted cardiac devices, part II.

Authors:  Sergio L Pinski; Richard G Trohman
Journal:  Pacing Clin Electrophysiol       Date:  2002-10       Impact factor: 1.976

3.  Pacemakers and external interference.

Authors:  H Elmqvist
Journal:  Acta Med Scand Suppl       Date:  1976

Review 4.  Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment.

Authors:  N Goldschlager; A Epstein; P Friedman; E Gang; R Krol; B Olshansky
Journal:  Arch Intern Med       Date:  2001-03-12

5.  The influence of electromagnetic environment on the performance of artificial cardiac pacemakers.

Authors:  S Furman; B Parker; M Krauthamer; D J Escher
Journal:  Ann Thorac Surg       Date:  1968-07       Impact factor: 4.330

6.  Electromagnetic interference in implantable pacemakers.

Authors:  W Irnich; J M de Bakker; H J Bisping
Journal:  Pacing Clin Electrophysiol       Date:  1978-01       Impact factor: 1.976

7.  Interference in pacemakers.

Authors:  W Irnich
Journal:  Pacing Clin Electrophysiol       Date:  1984-11       Impact factor: 1.976

  7 in total
  2 in total

1.  Testing of common electromagnetic environments for risk of interference with cardiac pacemaker function.

Authors:  Maria Tiikkaja; Aapo L Aro; Tommi Alanko; Harri Lindholm; Heli Sistonen; Juha E K Hartikainen; Lauri Toivonen; Jukka Juutilainen; Maila Hietanen
Journal:  Saf Health Work       Date:  2013-07-20

2.  Electromagnetic interference in cardiac electronic implants caused by novel electrical appliances emitting electromagnetic fields in the intermediate frequency range: a systematic review.

Authors:  Sarah Driessen; Andreas Napp; Kristina Schmiedchen; Thomas Kraus; Dominik Stunder
Journal:  Europace       Date:  2019-02-01       Impact factor: 5.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.